… docetaxel and cisplatin … study, a phase II prospective randomized trial comparing the efficacy
and toxicity of PF and DP regimens with CCRT in patients with ESCC. After the 5-year follow…

… every 3 weeks) followed by … adjuvant setting of stage III gastric cancer. However, to make
a better conclusion, the efficacy of DCF should be tested in a better designed, randomized study…

… This randomized study assessed the safety and efficacy of … treatment (surgery alone v surgery
plus adjuvant therapy v no … ,30 or cisplatin 25 mg/m 2 over 1 hour followed by gemcitabine …

… in perioperative and adjuvant therapy of localised gastroesophageal … of docetaxel into the
perioperative and adjuvant protocols. Perioperative 5-FU, folinic acid, oxliplatin and docetaxel (…

… , leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer:
… at last follow-up. One patient did not have a CT scan after study treatment; however, the …

… 1,100 were randomized to adjuvant treatment with either 5‐fluorouracil plus leucovorin (5‐FU/LV)
or sequential FOLFIRI regimen for four cycles, followed by cisplatin and docetaxel for …

… There were 243 patients in that one to one randomized study … Median follow-up time was
10.3 months in this study. The ORR … received second-line treatment with FOLFIRI in our study. …

… Objective: This study aimed to assess the efficacy and safety of FOLFIRI and paclitaxel in …
(AGC) who were previously treated with first-line modified docetaxel, cisplatin, 5-fluorouracil (…

… to improve treatment results by adding adjuvant or … -line treatments were only recorded for
22 patients. The most common schemes used in these patients were FOLFIRI (n = 7), followed …

… If patients recurred after having neoadjuvant or adjuvant chemotherapy with CF therapy…
docetaxel was administered on days 1 and 15, followed by a 2-h intravenous infusion of cisplatin …